炎症性肠道疾病中的肠道屏障:参考书目和知识图分析
Feng Zhou1, Nan-Zhen Wu2, Yong Xie1
1Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi Province, China.
World journal of gastroenterology
|October 30, 2023
概括
在炎症性肠道疾病 (IBD) 的肠道屏障研究趋势显示了快速的发展. 准肠道微生物群和新陈代谢为改善IBD炎症和预后提供了有希望的治疗策略.
科学领域:
- 胃肠道学和免疫学
- 生物医学研究生物医学研究
- 科学文献分析 科学文献分析
背景情况:
- 表皮屏障表面对于肠道的生理和免疫恒温至关重要.
- 肠道屏障的破坏与炎症性肠道疾病 (IBD) 有关.
- 了解肠道屏障功能是管理IBD的关键.
研究的目的:
- 在IBD的背景下分析肠道屏障研究的发展趋势和研究热点.
- 确定对这一领域做出贡献的关键出版物,机构,作者和期刊.
- 绘制研究主题的演变和兴趣的新兴领域的地图.
主要方法:
- 2002年至2022年间发表的4482篇文章的图书统计分析,来自Web of Science核心集合.
- 使用VOSviewer,CiteSpace和R软件进行数据可视化和分析.
- 确定了高频关键词和新兴研究主题.
主要成果:
- 美国在研究成果方面处于领先地位,芝加哥大学是主要机构.
- 高频关键词包括核因子kappa B,瘤亡因子-α,亡,氧化应激和益生菌.
- 新兴的研究重点是抗氧化剂,Akkermansia muciniphila,纳米粒子,短链脂肪酸和细胞外囊泡.
结论:
- 在IBD的肠道屏障研究领域正在迅速推进,有着重要的国际合作.
- 针对肠道微生物群和饮食代谢,为IBD提供了有希望的治疗途径.
- 认识到肠道屏障的作用为管理炎症和改善IBD患者预后提供了新的视角.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Inflammatory Bowel Disease II: Crohn's Disease
263
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
263
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Chronic Bowel Disorders: Introduction
459
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
459
Irritable Bowel Syndrome I: Introduction
284
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
284


